Yang XM, Yang XY, Wang XY, Gu YX. Influence of transcatheter arterial embolization on symptom distress and fatigue in liver cancer patients. World J Gastrointest Oncol 2024; 16(3): 810-818 [PMID: 38577467 DOI: 10.4251/wjgo.v16.i3.810]
Corresponding Author of This Article
Yue-Xia Gu, MBBS, Chief Nurse, Department of Nursing, Shanghai Fourth People’s Hospital Affiliated to Tongji University School of Medicine, No. 1279 Sanmen Road, Hongkou District, Shanghai 200434, China. shdsyy_guyuexia@163.com
Research Domain of This Article
Nursing
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Oncol. Mar 15, 2024; 16(3): 810-818 Published online Mar 15, 2024. doi: 10.4251/wjgo.v16.i3.810
Influence of transcatheter arterial embolization on symptom distress and fatigue in liver cancer patients
Xu-Min Yang, Xu-Yan Yang, Xin-Yu Wang, Yue-Xia Gu
Xu-Min Yang, Xu-Yan Yang, Department of Nursing, The First Affiliated Hospital of Naval Medical University (Changhai Hospital), Shanghai 200433, China
Xin-Yu Wang, Department of Thyroid, Breast and Vascular Surgery, Shanghai Fourth People’s Hospital Affiliated to Tongji University School of Medicine, Shanghai 200434, China
Yue-Xia Gu, Department of Nursing, Shanghai Fourth People’s Hospital Affiliated to Tongji University School of Medicine, Shanghai 200434, China
Author contributions: Gu YX and Yang XM contributed equally in analysis of the data and writing of the manuscript; Wang XY and Yang XY collected the data and corrected the paper; all authors have read and approved the final manuscript.
Institutional review board statement: The study was reviewed and approved by the Shanghai Fourth People’s Hospital Institutional Review Board (approval No. 2022108-001).
Informed consent statement: All patients provided informed consent for the surgical procedures.
Conflict-of-interest statement: The authors declare no conflicts of interest.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yue-Xia Gu, MBBS, Chief Nurse, Department of Nursing, Shanghai Fourth People’s Hospital Affiliated to Tongji University School of Medicine, No. 1279 Sanmen Road, Hongkou District, Shanghai 200434, China. shdsyy_guyuexia@163.com
Received: September 26, 2023 Peer-review started: September 26, 2023 First decision: December 5, 2023 Revised: December 22, 2023 Accepted: February 7, 2024 Article in press: February 7, 2024 Published online: March 15, 2024 Processing time: 167 Days and 21.1 Hours
Abstract
BACKGROUND
Hepatocellular carcinoma (HCC) is a prevalent malignancy, and transcatheter arterial embolization (TAE) has emerged as a pivotal therapeutic modality. However, TAE may induce symptom distress and fatigue, adversely affecting the quality of life of patients.
AIM
To investigate symptom distress, fatigue, and associated factors in HCC patients undergoing TAE.
METHODS
We used a cross-sectional design and purposive sampling to enroll HCC patients who underwent TAE at our institution from January to December 2022. Questionnaires were utilized to collect data on symptom distress and fatigue scores from the first to the third day after TAE.
RESULTS
Our study revealed a significant reduction in fatigue and symptom distress among patients after TAE. Pain, fatigue, insomnia, fever and abdominal distension were the most common symptoms troubling patients during the first 3 d post-TAE. Marital status, presence of family support, physical functional status, age, and symptom distress were identified as predictors of fatigue in patients.
CONCLUSION
Healthcare professionals should educate HCC patients on symptom distress and fatigue, offering personalized relief strategies to lessen their psychological burden.
Core Tip: Our study highlights the impact of transcatheter arterial embolization (TAE) on symptom distress and fatigue in liver cancer patients. TAE significantly reduced symptom distress and fatigue levels in the immediate postoperative period. The most commonly reported post-TAE symptoms included pain, fatigue, insomnia, fever and abdominal distension. Marital status, presence of family support, physical functional status, age, and symptom distress were identified as predictors of post-TAE fatigue. This research underscores the importance of patient education and personalized symptom management strategies in improving the overall wellbeing and quality of life for liver cancer patients undergoing TAE.
